Mayo Clinic trial to use stem cells to treat infant heart defects

The Mayo Clinic has received federal approval for a trial that will use autologous umbilical cord stem cells to treat hypoplastic left heart syndrome. The trial will commence upon the enrollment of 10 eligible patients, who will undergo three repair surgeries.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.) · KTTC-TV (Minn)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT